|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 287.20 CHF | +0.38% |
|
+7.00% | +12.41% |
| 07:37 | Roche erzielt mit Brustkrebsmittel Giredestrant Forschungserfolg | AW |
| 07:30 | Roches Brustkrebs-Medikamentenkandidat zeigt Verbesserungen gegenüber Standardtherapie | MT |
Roche Holding AG Gruppe: Beziehungs-Chart
Private Unternehmen, die zur gleichen Gruppe wie ROCHE HOLDING AG gehören
| Unternehmen | Manager |
|---|---|
Roche Pharmholding BV
 Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. | - |
Roche Intertrade Ltd. | - |
Roche Financial Investments Ltd. | - |
Roche Catalyst Investments Ltd. | - |
Roche Finance Europe BV | - |
Roche Diagnostics Belgium NV
 Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. | Thomas Schinecker |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition